Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
CHE vs CSV vs SCI vs ADUS vs ENSG
Revenue, margins, valuation, and 5-year total return — side by side.
Personal Products & Services
Personal Products & Services
Medical - Care Facilities
Medical - Care Facilities
CHE vs CSV vs SCI vs ADUS vs ENSG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Personal Products & Services | Personal Products & Services | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $5.82B | $705M | $10.89B | $1.81B | $10.18B |
| Revenue (TTM) | $2.54B | $416M | $4.33B | $1.45B | $5.27B |
| Net Income (TTM) | $260M | $44M | $626M | $100M | $363M |
| Gross Margin | 22.5% | 35.3% | 26.2% | 32.5% | 15.2% |
| Operating Margin | 12.9% | 22.3% | 22.4% | 9.8% | 8.5% |
| Forward P/E | 17.5x | 12.9x | 18.8x | 14.1x | 23.2x |
| Total Debt | $155M | $563M | $5.14B | $209M | $4.15B |
| Cash & Equiv. | $75M | $2M | $244M | $82M | $504M |
CHE vs CSV vs SCI vs ADUS vs ENSG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Chemed Corporation (CHE) | 100 | 89.0 | -11.0% |
| Carriage Services, … (CSV) | 100 | 237.6 | +137.6% |
| Service Corporation… (SCI) | 100 | 199.1 | +99.1% |
| Addus HomeCare Corp… (ADUS) | 100 | 98.3 | -1.7% |
| The Ensign Group, I… (ENSG) | 100 | 398.7 | +298.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CHE vs CSV vs SCI vs ADUS vs ENSG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CHE has the current edge in this matchup, primarily because of its strength in sleep-well-at-night.
- Lower volatility, beta 0.33, Low D/E 15.8%, current ratio 1.05x
- 0.5% yield, 18-year raise streak, vs SCI's 1.6%, (1 stock pays no dividend)
- 15.9% ROA vs CSV's 3.3%, ROIC 23.7% vs 9.4%
CSV ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.44 vs SCI's 3.30
- Lower P/E (12.9x vs 23.2x), PEG 0.44 vs 1.68
SCI is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 12 yrs, beta 0.11, yield 1.6%
- Beta 0.11, yield 1.6%, current ratio 0.55x
- 14.5% margin vs ADUS's 6.9%
- Beta 0.11 vs CSV's 0.66
ADUS is the clearest fit if your priority is growth exposure.
- Rev growth 23.2%, EPS growth 23.2%, 3Y rev CAGR 14.4%
- 23.2% revenue growth vs SCI's 2.9%
ENSG is the clearest fit if your priority is long-term compounding.
- 7.5% 10Y total return vs ADUS's 399.9%
- +27.5% vs CHE's -25.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.2% revenue growth vs SCI's 2.9% | |
| Value | Lower P/E (12.9x vs 23.2x), PEG 0.44 vs 1.68 | |
| Quality / Margins | 14.5% margin vs ADUS's 6.9% | |
| Stability / Safety | Beta 0.11 vs CSV's 0.66 | |
| Dividends | 0.5% yield, 18-year raise streak, vs SCI's 1.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +27.5% vs CHE's -25.9% | |
| Efficiency (ROA) | 15.9% ROA vs CSV's 3.3%, ROIC 23.7% vs 9.4% |
CHE vs CSV vs SCI vs ADUS vs ENSG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CHE vs CSV vs SCI vs ADUS vs ENSG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SCI leads in 2 of 6 categories
CSV leads 1 • CHE leads 1 • ENSG leads 1 • ADUS leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SCI leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ENSG is the larger business by revenue, generating $5.3B annually — 12.7x CSV's $416M. SCI is the more profitable business, keeping 14.5% of every revenue dollar as net income compared to ADUS's 6.9%. On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.5B | $416M | $4.3B | $1.4B | $5.3B |
| EBITDAEarnings before interest/tax | $377M | $116M | $1.2B | $159M | $558M |
| Net IncomeAfter-tax profit | $260M | $44M | $626M | $100M | $363M |
| Free Cash FlowCash after capex | $377M | $40M | $629M | $137M | $406M |
| Gross MarginGross profit ÷ Revenue | +22.5% | +35.3% | +26.2% | +32.5% | +15.2% |
| Operating MarginEBIT ÷ Revenue | +12.9% | +22.3% | +22.4% | +9.8% | +8.5% |
| Net MarginNet income ÷ Revenue | +10.2% | +10.6% | +14.5% | +6.9% | +6.9% |
| FCF MarginFCF ÷ Revenue | +14.8% | +9.7% | +14.5% | +9.5% | +7.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +1.6% | -0.9% | +2.1% | +7.7% | +18.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -0.2% | -37.3% | +65.3% | +17.2% | +21.9% |
Valuation Metrics
CSV leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 13.7x trailing earnings, CSV trades at a 54% valuation discount to ENSG's 29.8x P/E. Adjusting for growth (PEG ratio), CSV offers better value at 0.46x vs SCI's 3.62x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $5.8B | $705M | $10.9B | $1.8B | $10.2B |
| Enterprise ValueMkt cap + debt − cash | $5.9B | $1.3B | $15.8B | $1.9B | $13.8B |
| Trailing P/EPrice ÷ TTM EPS | 23.12x | 13.68x | 20.66x | 18.67x | 29.85x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.49x | 12.95x | 18.79x | 14.12x | 23.19x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.46x | 3.62x | 0.93x | 2.16x |
| EV / EBITDAEnterprise value multiple | 14.65x | 10.16x | 12.01x | 12.52x | 25.71x |
| Price / SalesMarket cap ÷ Revenue | 2.30x | 1.69x | 2.53x | 1.28x | 2.01x |
| Price / BookPrice ÷ Book value/share | 6.26x | 2.73x | 6.83x | 1.65x | 4.59x |
| Price / FCFMarket cap ÷ FCF | 17.89x | 17.60x | 19.65x | 17.48x | 27.46x |
Profitability & Efficiency
CHE leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
SCI delivers a 39.4% return on equity — every $100 of shareholder capital generates $39 in annual profit, vs $9 for ADUS. CHE carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to SCI's 3.14x. On the Piotroski fundamental quality scale (0–9), SCI scores 7/9 vs ENSG's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +25.3% | +17.6% | +39.4% | +9.3% | +16.6% |
| ROA (TTM)Return on assets | +15.9% | +3.3% | +3.4% | +7.0% | +6.8% |
| ROICReturn on invested capital | +23.7% | +9.4% | +11.3% | +8.8% | +7.0% |
| ROCEReturn on capital employed | +24.7% | +7.9% | +5.6% | +10.9% | +10.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 7 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.16x | 2.21x | 3.14x | 0.19x | 1.86x |
| Net DebtTotal debt minus cash | $80M | $561M | $4.9B | $127M | $3.7B |
| Cash & Equiv.Liquid assets | $75M | $2M | $244M | $82M | $504M |
| Total DebtShort + long-term debt | $155M | $563M | $5.1B | $209M | $4.2B |
| Interest CoverageEBIT ÷ Interest expense | 107.24x | 3.24x | 3.78x | 14.45x | 88.33x |
Total Returns (Dividends Reinvested)
ENSG leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $8,883 for CHE. Over the past 12 months, ENSG leads with a +27.5% total return vs CHE's -25.9%. The 3-year compound annual growth rate (CAGR) favors ENSG at 23.6% vs CHE's -7.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +0.6% | +7.7% | +2.1% | -8.7% | +0.3% |
| 1-Year ReturnPast 12 months | -25.9% | +9.8% | +4.9% | -13.4% | +27.5% |
| 3-Year ReturnCumulative with dividends | -21.9% | +69.5% | +25.3% | +16.3% | +88.9% |
| 5-Year ReturnCumulative with dividends | -11.2% | +21.1% | +50.6% | +0.0% | +103.2% |
| 10-Year ReturnCumulative with dividends | +241.8% | +102.1% | +225.6% | +399.9% | +752.0% |
| CAGR (3Y)Annualised 3-year return | -7.9% | +19.2% | +7.8% | +5.2% | +23.6% |
Risk & Volatility
SCI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SCI is the less volatile stock with a 0.11 beta — it tends to amplify market swings less than CSV's 0.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SCI currently trades 88.5% from its 52-week high vs CHE's 72.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.33x | 0.66x | 0.11x | 0.58x | 0.42x |
| 52-Week HighHighest price in past year | $583.96 | $52.14 | $88.67 | $124.44 | $218.00 |
| 52-Week LowLowest price in past year | $365.20 | $39.88 | $74.31 | $90.89 | $133.81 |
| % of 52W HighCurrent price vs 52-week peak | +72.9% | +85.3% | +88.5% | +78.2% | +80.0% |
| RSI (14)Momentum oscillator 0–100 | 64.7 | 43.9 | 37.7 | 49.3 | 23.3 |
| Avg Volume (50D)Average daily shares traded | 274K | 100K | 1.2M | 236K | 358K |
Analyst Outlook
Evenly matched — CHE and SCI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CHE as "Hold", CSV as "Buy", SCI as "Buy", ADUS as "Buy", ENSG as "Buy". Consensus price targets imply 32.3% upside for ADUS (target: $129) vs 11.5% for CHE (target: $475). For income investors, SCI offers the higher dividend yield at 1.64% vs ENSG's 0.14%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $475.00 | $50.00 | $93.00 | $128.67 | $222.33 |
| # AnalystsCovering analysts | 9 | 7 | 9 | 15 | 13 |
| Dividend YieldAnnual dividend ÷ price | +0.5% | +1.0% | +1.6% | — | +0.1% |
| Dividend StreakConsecutive years of raises | 18 | 6 | 12 | 2 | 12 |
| Dividend / ShareAnnual DPS | $2.20 | $0.45 | $1.29 | — | $0.24 |
| Buyback YieldShare repurchases ÷ mkt cap | +7.4% | 0.0% | +4.2% | 0.0% | +0.2% |
SCI leads in 2 of 6 categories (Income & Cash Flow, Risk & Volatility). CSV leads in 1 (Valuation Metrics). 1 tied.
CHE vs CSV vs SCI vs ADUS vs ENSG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CHE or CSV or SCI or ADUS or ENSG a better buy right now?
For growth investors, Addus HomeCare Corporation (ADUS) is the stronger pick with 23.
2% revenue growth year-over-year, versus 2. 9% for Service Corporation International (SCI). Carriage Services, Inc. (CSV) offers the better valuation at 13. 7x trailing P/E (12. 9x forward), making it the more compelling value choice. Analysts rate Carriage Services, Inc. (CSV) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CHE or CSV or SCI or ADUS or ENSG?
On trailing P/E, Carriage Services, Inc.
(CSV) is the cheapest at 13. 7x versus The Ensign Group, Inc. at 29. 8x. On forward P/E, Carriage Services, Inc. is actually cheaper at 12. 9x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Carriage Services, Inc. wins at 0. 44x versus Service Corporation International's 3. 30x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CHE or CSV or SCI or ADUS or ENSG?
Over the past 5 years, The Ensign Group, Inc.
(ENSG) delivered a total return of +103. 2%, compared to -11. 2% for Chemed Corporation (CHE). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus CSV's +102. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CHE or CSV or SCI or ADUS or ENSG?
By beta (market sensitivity over 5 years), Service Corporation International (SCI) is the lower-risk stock at 0.
11β versus Carriage Services, Inc. 's 0. 66β — meaning CSV is approximately 482% more volatile than SCI relative to the S&P 500. On balance sheet safety, Chemed Corporation (CHE) carries a lower debt/equity ratio of 16% versus 3% for Service Corporation International — giving it more financial flexibility in a downturn.
05Which is growing faster — CHE or CSV or SCI or ADUS or ENSG?
By revenue growth (latest reported year), Addus HomeCare Corporation (ADUS) is pulling ahead at 23.
2% versus 2. 9% for Service Corporation International (SCI). On earnings-per-share growth, the picture is similar: Carriage Services, Inc. grew EPS 54. 8% year-over-year, compared to -7. 4% for Chemed Corporation. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CHE or CSV or SCI or ADUS or ENSG?
Service Corporation International (SCI) is the more profitable company, earning 12.
6% net margin versus 6. 7% for Addus HomeCare Corporation — meaning it keeps 12. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CSV leads at 23. 7% versus 8. 6% for ENSG. At the gross margin level — before operating expenses — CSV leads at 35. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CHE or CSV or SCI or ADUS or ENSG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Carriage Services, Inc. (CSV) is the more undervalued stock at a PEG of 0. 44x versus Service Corporation International's 3. 30x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carriage Services, Inc. (CSV) trades at 12. 9x forward P/E versus 23. 2x for The Ensign Group, Inc. — 10. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ADUS: 32. 3% to $128. 67.
08Which pays a better dividend — CHE or CSV or SCI or ADUS or ENSG?
In this comparison, SCI (1.
6% yield), CSV (1. 0% yield), CHE (0. 5% yield), ENSG (0. 1% yield) pay a dividend. ADUS does not pay a meaningful dividend and should not be held primarily for income.
09Is CHE or CSV or SCI or ADUS or ENSG better for a retirement portfolio?
For long-horizon retirement investors, Service Corporation International (SCI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
11), 1. 6% yield, +225. 6% 10Y return). Both have compounded well over 10 years (SCI: +225. 6%, ADUS: +399. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CHE and CSV and SCI and ADUS and ENSG?
These companies operate in different sectors (CHE (Healthcare) and CSV (Consumer Cyclical) and SCI (Consumer Cyclical) and ADUS (Healthcare) and ENSG (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CHE is a small-cap quality compounder stock; CSV is a small-cap deep-value stock; SCI is a mid-cap quality compounder stock; ADUS is a small-cap high-growth stock; ENSG is a mid-cap high-growth stock. CHE, CSV, SCI pay a dividend while ADUS, ENSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.